Jefferies Downgrades Abivax to Hold, Lowers Price Target to $90

Benzinga Newsdesk www.benzinga.com Negative 90.5%

Neg 90.5% Neu 0% Pos 0%

Jefferies analyst Faisal Khurshid downgrades Abivax (NASDAQ:ABVX) from Buy to Hold and lowers the price target from $160 to $90.